The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is
- To evaluate the efficacy of PRC-4016 by assessment of the percentage change in blood
lipids and lipoprotein parameters from baseline after 12 weeks of treatment.
- To evaluate the safety of PRC-4016 as assessed by adverse events and other safety
parameters